Advanced search
Publication Cover
Journal of Nutritional & Environmental Medicine Volume 8, 1998 - Issue 1
Journal homepage
15
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Syndromes Associated with Silicone Breast Implants: A Clinical Study and Review

ARTHUR DALE ERICSSON MD Institute of Biologic Research, 6560 Fannin, Suite 720, Houston, TX 77030, USA
Pages 35-51 | Published online: 13 Jul 2009

  • Ostenmeyer B, Patten BM, Calkins DS. Adjuvant breast disease: a clinical evaluation of 100 symptomatic women with silicone breast implants or silicone fluid injections into the breast, Keio Med J 1994; 43: 79-87.
  • Lappe, M. `Nonreactive' Chemicals lack Adverse Effects in Chemical Deception. San Francisco: Sierra Club Books, 1991.
  • Kessler DA, Merkatz RB, Schapiro R. A call for higher standards for breasts implants. JAMA 1993; 270: 2607-8.
  • Kessler DA. The basis of the FDA's decision of breast implants. N Engl J Med 1992; 326: 1713-15.
  • Kumagai Y, Shiokawa Y, Medsger TA, et al. Clinical spectrum of connective tissue disease after cosmetic surgery, Arthrit Rheumat 1984; 27: 1-12.
  • Kossovsky N, Heggers JP, Robson MC. The bioreactivity of silicone. Crit Rev Biocompat 1997; 3: 53-85.
  • Hausner R, Schoen FJ, Pierson KK. Foreign body reaction of silicone-gel in axillary lymph nodes after augmentation mammoplasty. Plastic Reconstruct Surg 1978; 62: 381-3.
  • Hilts PJ, Maker of implants says-silicone-gel poses health risks. Houston Chron 1993; 20 March: 1-2.
  • Cronin T, Gerow F. Augmentation mammoplasty, a new natural fell prosthesis. In: Transactions of the Third International Congress of Plastic and Reconstructive Surgery. Amsterdam: Excerpta Medica, 1964; 41-2.
  • Brozerna SJ. Fenske NA, Cruse CW et al. Human adjuvant disease following augmentation mammoplasty. Arch Dermatol 1988; 124: 1383-6.
  • Cuellar M, et al. Silicone breast implants associated with musculo-skeletal manifestations. Clin Rheumat 1995; 14: 667-72.
  • Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations. The FDA's Regulation of Silicone Breast Implants. Washington, DC: US Government Printing Office, 1992.
  • Heggers JP, Kossovsky N, Parsons RW, et al. Biocompatability of silicone implants. Ann Plastic Surg 1983; 11: 38-45.
  • Jenny H, Smahe L. Clinicopathological correlation in pseudocapsule formation after breast augmentation. Aesth Plastic Surg 1981; 5: 63-8.
  • Kessel RWI, Monaco L, Marchisio MA. The specificity of the cytotoxic action of silica. A study in vitro. Br J Exp Pathol 1963; 44: 351-64.
  • Kaiser W, Beisenback W, Stuby U. et al. Human adjuvant disease: remission of silicone-induced autoimmune disease after explantation of breast augmentation. Ann Rheumat Dis 1990; 49: 937-8.
  • Batich C, DePalma D. Materials used in breast implants: silicones and polyurethanes. J Long-Term Effects Med Implants 1992; 1: 255-68.
  • Allison AC, Harrington JS, Birbeck M. An examination of the cytotoxic effects of silica on macrophages. J Exp Med 1966; 124: 141-53.
  • Argenta LC. Migration of silicone get into breast parenchyma following mammary prosthesis rupture. Aesth Plastic Surg 1983; 7: 253-4.
  • Baldwin CM, Kaplan EN. Silicone induced human adjuvant disease. Ann Plastic Surg 1983; 10: 270-3.
  • Barker DE, Retsky MI, Schultz S. Bleeding of silicone from bag-gel breast implants and its clinical relation to fibrous capsule reaction. Plastic Reconstruct Surg 1978; 61: 836-41.
  • Batich C. Silicone degradation products. In: NIH Immunology of Silicones Workshop, 13-14 March 1995.
  • Garrido L, Detection of Silicone Migration with NMR. In: NIH Immunology of Silicones Workshop, 13-14 March 1995.
  • Garrido L. Pfleiderer B, Papisow M. et al. In vivo degradation of silicones, NRM 1993; 29: 839-43.
  • Goldblum RM, Pelley RP, O'Donell AA, et al. Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts. Lancet 1992; 340: 510-13.
  • Guthrie JL, McKinney RW, Determination of 2,4 and 2.6 diaminotoluene in flexible urethane foam. Anal Chem 1977; 49: 1676-80.
  • Harrison M. Adjuvancy and breast implants. Dow Corning Commun 1993; 4 March: 1-2.
  • Pernis B, Parnetto F. Adjuvant effect of silica (tridymite) on antibody production. Proc Soc Exp Biol Med 1962; HQ 390-2.
  • Lake RS, Radonovich H. Action of Polydimethylsiloxanes on the Reticuloendothelial System of Mice: Basic Cellular Interactions and Structure-Activity Relationship. Midland, MI: Dow Corning Corporation, Research Department, 1975.
  • Pfleiderer B, et al. Migration and biodegradation of free silicone from silicone gel-filled implants after long-term implantation. Magnet Res Med 1993; 30: 534-43.
  • Uber CL, McReynold RA. Immunotoxicology of silica. CRC Crit Rev Toxicol 1982; 10: 303-19.
  • Picha GJ, Goldstein JA, Stohr F. Natural-Y meme polyurethane versus smooth silicone: analysis of the soft-time interaction from 3 days to year in the rat animal model. Plastic Reconstruct Surg 1990; 85: 903-16.
  • Kossovsky N, Freiman S. Silicone breast implant pathology: clinical data and immunologic consequences. Arch Pathol Lab Med 1994: 118: 686-93.
  • Vodjani A, Campbell A, Brautbar N. Immune functional abnormalities in patients with clinical abnormalities and silicone breast implants. Toxicol Ind Health 1992; 8: 415-29.
  • Nam JO, Lanzafame RJ, van Oss CJ. The adjuvant effect of silicone gel on antibody formation in rats. Immunol Invest 1991; 22: 151-61.
  • Black DL. 2,4-TDA analysis with regards to PUF breast implants. Aegis Anal Lab Commun 1991: 4 June: 1-2 and 1993; August 11: 3-4.
  • Kossovsky N, Heggers JP, Robson MC. Experimental demonstration of the immunogenecity of silicone-protein complexes. J Biomed Mater Res 1987; 21: 1125-33.
  • Wolf C, et al. Chemical analysis of explanted breast implants. In: NIH Immunology of Silicones Workshop. 1995.
  • Bergman RB, van der Ende AE. Exudation of silicone through the envelope of gel filled breast prostheses: an in-vitro study. Br J Plastic Sure 1979; 32: 31-4.
  • Lust JA. The role of cytokines in the pathogenesis of monoclonal gammopathies. Mayo Clin Bull 1994; 69: 691-7.
  • Rodnan GP, Bendek TG, Medsger TA, et al. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann intern Med 1960; 66: 323-8.
  • Swan S. Epidemiology of silicone-related disease. Sem Arthrit Rheumat 1994; 24 (Suppl 1): 38-43.
  • Tasher A, Broughton A. An ELISA method for detecting serum antibodies. Clin Chem 1993; 39: 1247-9.
  • Sergott TJ, Limoli JP, Baldwin CM et al. Human adjuvant disease; possible autoimmune disease after silicone implantation: a review of the literature case studies and speculation for the future. Plastic Reconstruct Surg 1984; 78: 104-14.
  • Sahn EE, Garen PD, Silver RM et al. Scleroderma following augmentation mammoplasty. Arch Dermatol 1990; 126: 1198-202.
  • Schmidt GH. Mammary implant shell failure. Ann Plastic Surg 1980; 5: 369-71.
  • Chan SC, Birdsell DC, Gradeen CY. Detection of toluenediamines in the urine of a patient with polyurethane-covered breast implants. Clin Chem 1991: 37: 756-8.
  • Gayou R, Rudolph R. Capsular contraction around silicone mammary prostheses. Ann Plastic Surg 1979; 2: 62-71.
  • Capozzi A, Du Bou R, Pennisi VR. Distant migration of silicone-gel from a ruptured breast implant. Plastic Reconstuct Surg 1978; 62: 302-3.
  • Cocke WM Jr, Sampsom HW. Silicone bleed associated with double-lumen breast prostheses. Ann Surg 1979; 18: 524-6.
  • Ostermeyer B, Patten BM. Abnormal laboratory and histopathological findings in women with systemic disease and saline breast implants. Brain Pathol 1994; 15: 376-9.
  • Ostermeyer B, Patten BM. An atypical motor neuron disease syndrome in patients with breast implants. Can J Neurol Sci 1994; 1 (Suppl 2): 64-9.
  • Lee L, Ostermeyer B, Patten BM. An atypical chest pain syndrome in silicone breast implant patients. S Med J 1994; 87: 978-84.
  • Vargas A. Shedding of silicone particles form inflated breast implants. Plastic Reconstruct Surg 1979; 64: 252-3.
  • Travis WD, Balogh K, Abraham JJ. Silicone granulomas: report of three cases and review of the literature. Human Pathol 1985; 16: 19-26.
  • Miyoshi K, Miyamura T. Kobayashi Y. et al. Hypergammaglobulinemia by prolonged adjuvanticity in man. Disorders developed after augmentation mammoplasty. Jpn Med J 1964; 21221: 9-14.
  • Van Nunen SA, Gatenby PA, Basten A. Post-mammoplasty connective tissue disease. Arthrit Rheumat 1982; 25: 694-7.
  • Endo LP, Edwards NL, Longley G, et al. Silicone and rheumatic diseases. Sent Arthrit Rheumat 1987; 47: 112-18.
  • Varga J, Schumacher HR, Jimenez SA. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 1989; 149: 1194-6.
  • Varga J, Jimenez SA. Augmentation mammoplasty and scleroderma. Arch Dermatol 1990; 126: 1220-2.
  • Ericsson AD, DeGeorge J. The story of silicone. Explore 1996; 6: 13-16.
  • Fock KM, Feng PH, Tey BH. Autoimmune disease developing after augmentation mammoplasty: report of 3 cases. J Rheumat 1984; 11: 98-100.
  • Gelfand EW. Intervention in autoimmune disorders. Clin Immunol Immunopathol 1989; 53: S1-6.
  • Package Insert. Arlington, TX: Dow Corning Wright 1991.
  • Trachman H. Ilowite N, Levine J. Increased urinary NO and NO excretion in children breast fed by mothers with silicone implants (SI). Arthrit Rheumatol 1994; 37: s422.
  • Truong LD, Cartwright J, Goodman D, et al. Silicone lymphadenopathy associated with augmentation mammoplasty, Morphologic features of nine cases. Am J Surg Pathol 1988; 12: 484-91.
  • Uretsky BF, O'Brien JJ, Courtiss EH, et al. Augmentation mammoplasty associated with a severe systemic illness. Anti Plastic Surg 1979; 3: 445-7.
  • Walsh FW, Solomon DA, Espinosa LR. et al. Human adjuvant disease. A Cause of chylous effusions. Arch Intern Med 1989; 149: 1194-6.
  • Celli B, Texter S. Kovnat DM. Case report: adult respiratory distress syndrome following mammary augmentation. Am J Med Sci 1978; 275: 81-5.
  • Rechlin S. Neuroendocrine-Immune interactions. N Eng J Med 1993; 329: 1246-52.
  • Broughton A, Trasher JD. Auto-antibodies associated with silicone breast implants. Clin Chem 1993; 39: 1139-40.
  • Morse JH, Spiera H. Autoimmune disease immunoglobulin isotypes and lymphocyte subsets in 30 females with breast augmentation mammplasty Arthrit Rheumat 1992; 35: 65-7.
  • Mancino D, Vuotto ML, Minucci M. Effects of a crystalline silica oil antibody production to t-independent and t-independent antigens in bald/c mice. Int Arch Allergy Appl Immunol 1984; 73: 10-13.
  • Bar-Meir E, Teuber SS, Lin HC, et al. Autoantibody profile of women with silicone breast implants. Arch Rheumat 1994; 37: s422 (9-12).
  • Bridges AJ, Conley C., Wang G, et al. A clinical immunological evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med 1993; 118: 929-36.
  • Silver R Sahn EE, Allen JA. et al. Demonstration of silicon in slides of connective-tissue disease in patients with silicone-gel breast implants. Arch Dermatol 1993; 129: 63-8.
  • Silverman S, Mendoza M, Silver D, et al. Measurement of fatigue in patients with silicone breast implants (SBI) as compared to fibromyalgia (FM) and rheumatoid arthritis (RA). Arthrit Rheumat 1994; 37: S271, 4-6.
  • Love LA, Weiner SR, Vasey FB, et al. Clinical and immunogenetic features of women who developed myositis after silicone implants. Arthrit Rheumat 1992; 35: 46-8.
  • Freundlich B, Tomaszewski J, Callegari P. A Sjogren's-like syndrome in women with silicone-gel breast implants. Arthrit Rheumat 1992; 35: 67-9.
  • Tenenbaum SA, Silveira LH, Martinez-Osuma P, et al. Identification of a novel auto-antigen recognized in silicone associated connective tissue disease. Arthrit Rheumat 1992; 35: 73-5.
  • Ostermeyer B, Patten BM. An MS-like syndrome in women with silicone breast implants or silicone fluid injections in breast. Neurology 1994; 44: A158: 37-44.
  • Ostermeyer B. and Patten BM. Human adjuvant disease presenting as multiple sclerosis-like syndrome. S Med J 1996; 89: 179-88.
  • Levine J, Ilowite N. Scleroderma-like esophageal disease in children breast-fed by mothers with silicone breast implants. JAMA 1994; 271: 213-16.
  • Gutierrez FJ, Espinosa LR. Progressive systemic sclerosis complicated by severe hypertension; reversal after silicone implant removal. Am J Med 1990; 89: 390-2.
  • Young, V. et al. HLA typing in women with breast implants. Plastic Reconstruct Surg 1995; 96: 1497-519.
  • Jekel J, et al, Epidemiology biostatistics and preventive medicine. Philadelphia, PA: W. B. Saunders, 1990.
  • Rosenberg N. The neuromythology of silicone breast implants. Neurology 1996; 310: 308-14.
  • Weisman MH, Vecchione TR, Albert D, et al. Connective tissue disease following breast augmentation: a preliminary test of the human adjuvant hypothesis. Plast Reconstr Surg 1988; 82: 626-30.
  • Bright RA, Jeng LL, Moore RM. National survey of self-reported breast implants: 1988 estimates. J Long-Term Effects Med Implants 1993; 3: 81-9.
  • Okano V. Nishikai M. Sato A. Scleroderma, primary biliary cirrhosis and Sjogren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheumat Dis 1984; 43: 520-1.
  • Oxelius V. Immunoglobulin G subclasses and human disease. Am J Med 1984; 4: 7-18.
  • Kumagai Y. Abe C, and Shiokawa Y. Scleroderma after cosmetic Surgery. Arthrit Rheumat 1979; 22: 532-7.
  • Spiera H. Sclerodema after silicone augmentation mammoplasty. JAMA 1998; 260: 236-8.
  • DeCamara DL, Sheridan JM, Kammer BA. Rupture and aging of silicone gel breast implants. Plastic Reconstruct Surg 1993; 91: 828-34,
  • Cook RR, Delongchamp RR, Woodbury M. et al. Breast implant prevalence. Dow Corning Commun 1996: 17 March; 2-3.
  • Spiera H, Kerr L. Scleroderma following silicone implantation: a Cumulative experience of twelve cases. Arch Rheumat 1992; 35: 68-72.
  • Koeger C. Alxaix D. Rozenberg S, et al. Silica-induced connective tissue diseases do still occur Arthrit Rheumat 1993; 35: 34-7.
  • Jordan S. Intravenous gamma globulin therapy in systemic lupus erythematosis and immune complex disease. Clin Immunol Immunopathol 1989; 53: 164-9.
  • Dwyer JM. Intravenous therapy with gamma globulin, Adv Intern Med 1997; 32: 111-36.
  • Barrett J. Textbook of Immunology, St Louis: Mosby Company, 1988.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.